Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026.

Delve into Roche's strategy, a company originally built on oncology, now reinventing its pipeline in obesity and immunology.

Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

Delve into bronchiectasis, a field long focused on managing symptoms that now has its first targeted treatment with ...

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

Despite decades of progress in oncology, the majority of cancer drugs that enter clinical trials never reach the market and the patients who need them most. Late-stage failure remains one of the most ...

Home to the European Commission (EC), Belgium holds a reputation for life sciences and innovation in Europe. In the port city of Ghent, the Vlaams Instituut voor Biotechnologie (VIB) wants to bridge ...

The European life science sector remains a key driver of global innovation that is propelled by technological breakthroughs and a robust pipeline of novel therapies. But the European Union (EU) is ...

With one of the most densely concentrated life sciences and biotech ecosystems in Europe, the Netherlands is home to numerous biotech and pharmaceutical companies, and also happens to be the ...

A kind of immunotherapy, cancer vaccines have been around since the link between human papillomavirus (HPV) and cancer was discovered in the 1980s. For the prevention of cancers caused by the virus, ...